| 1 |
35324948 | CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults. | 2022 |
1 |
| 2 |
32368562 | Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine. | 2020 Apr |
1 |
| 3 |
32855823 | Immunologic Response of HIV-Infected Children to Different Regimens of Antiretroviral Therapy: A Retrospective Observational Study. | 2020 |
2 |
| 4 |
31597561 | Reasons for first line ART modification over the years during the ART scale up in Uganda. | 2019 Oct 9 |
1 |
| 5 |
29308748 | Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran. | 2018 |
3 |
| 6 |
29875890 | Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine versus Zidovudine-Lamivudine-Efavirenz Antiretroviral Treatment (ART) Among HIV-1 Infected Children: Asella Teaching and Referral Hospital, South-East Ethiopia. | 2018 |
2 |
| 7 |
26684818 | In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. | 2016 Jan |
1 |
| 8 |
27496003 | Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells. | 2016 Sep |
2 |
| 9 |
25756498 | Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis. | 2015 |
2 |
| 10 |
26208212 | Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast. | 2015 |
1 |
| 11 |
24025074 | Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission. | 2014 Apr |
1 |
| 12 |
23639243 | Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. | 2013 Apr 30 |
1 |
| 13 |
23660577 | Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa. | 2013 Sep 10 |
1 |
| 14 |
23691224 | Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study. | 2013 |
1 |
| 15 |
23962110 | The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma. | 2013 Aug 20 |
1 |
| 16 |
21087377 | Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal. | 2011 Feb |
1 |
| 17 |
20136661 | Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts. | 2010 May |
1 |
| 18 |
20235638 | Interferon-alpha produces significant decreases in HIV load. | 2010 Jul |
1 |
| 19 |
20648215 | Optimal dynamic regimes: presenting a case for predictive inference. | 2010 Mar 3 |
1 |
| 20 |
20942650 | A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa. | 2010 Nov 15 |
1 |
| 21 |
28299037 | Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital. | 2010 Sep 1 |
1 |
| 22 |
19207595 | Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy. | 2009 Mar |
2 |
| 23 |
18097230 | Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection. | 2008 Jan 11 |
2 |
| 24 |
18593347 | Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy. | 2008 Jul |
1 |
| 25 |
18957095 | A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. | 2008 Oct 28 |
1 |
| 26 |
19081791 | Three generic nevirapine-based antiretroviral treatments in Chinese HIV/AIDS patients: multicentric observation cohort. | 2008 |
1 |
| 27 |
17457087 | Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy. | 2007 May 11 |
6 |
| 28 |
18018762 | Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection. | 2007 |
1 |
| 29 |
16345047 | Survival analysis using auxiliary variables via non-parametric multiple imputation. | 2006 Oct 30 |
1 |
| 30 |
16378987 | R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors. | 2006 Jan |
1 |
| 31 |
16691065 | Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. | 2006 May 12 |
2 |
| 32 |
17310818 | Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. | 2006 |
1 |
| 33 |
15718842 | Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. | 2005 Feb 18 |
1 |
| 34 |
16464744 | Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7. | 2005 Dec |
1 |
| 35 |
14981673 | Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. | 2004 Mar 15 |
1 |
| 36 |
15167296 | Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa. | 2004 Jun 1 |
2 |
| 37 |
15472858 | Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults. | 2004 Oct 1 |
1 |
| 38 |
12571527 | Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. | 2003 Feb 1 |
1 |
| 39 |
12689411 | Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion. | 2003 Mar |
1 |
| 40 |
12769724 | Phospholipid analogs against HIV-1 infection and disease. | 2003 |
2 |
| 41 |
12902802 | Progression of HIV disease among women following delivery. | 2003 Aug 15 |
1 |
| 42 |
14571186 | Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. | 2003 Nov 7 |
1 |
| 43 |
14600578 | Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced disease. | 2003 Nov 1 |
1 |
| 44 |
11834944 | Effect of target cell availability on HIV-1 production in vitro. | 2002 Feb 15 |
2 |
| 45 |
12111906 | Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. | 2002 Jun 30 |
3 |
| 46 |
12215207 | L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. | 2002 Jun |
1 |
| 47 |
12403023 | A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. | 2002 Apr-Jun |
1 |
| 48 |
12630488 | Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya. | 2002 Nov |
2 |
| 49 |
11176271 | Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort. | 2001 Jan 1 |
2 |
| 50 |
11317074 | Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients. | 2001 Apr 1 |
1 |